Maninder Hora
2016
In 2016, Maninder Hora earned a total compensation of $1.5M as Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer at Nektar Therapeutics, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $279,875 |
|---|---|
| Option Awards | $432,450 |
| Salary | $447,800 |
| Stock Awards | $367,197 |
| Other | $14,454 |
| Total | $1,541,776 |
Hora received $447.8K in salary, accounting for 29% of the total pay in 2016.
Hora also received $279.9K in non-equity incentive plan, $432.5K in option awards, $367.2K in stock awards and $14.5K in other compensation.
Rankings
In 2016, Maninder Hora's compensation ranked 6,112th out of 14,075 executives tracked by ExecPay. In other words, Hora earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,112 out of 14,075 | 57th |
Division Manufacturing | 2,233 out of 5,486 | 59th |
Major group Chemicals And Allied Products | 734 out of 1,900 | 61st |
Industry group Drugs | 555 out of 1,543 | 64th |
Industry Pharmaceutical Preparations | 434 out of 1,173 | 63rd |
Source: SEC filing on April 30, 2018.
Hora's colleagues
We found four more compensation records of executives who worked with Maninder Hora at Nektar Therapeutics in 2016.
2016
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2016
John Nicholson
Nektar Therapeutics
Chief Operating Officer
2016
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
2016
Stephen Doberstein
Nektar Therapeutics